Cargando…

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

Detalles Bibliográficos
Autores principales: Willemse, P M, Burggraaf, J, Hamdy, N A T, Weijl, N I, Vossen, C Y, van Wulften, L, van Steijn-van Tol, A Q M J, Rosendaal, F R, Osanto, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708557/
http://dx.doi.org/10.1038/bjc.2013.358
_version_ 1782276629540634624
author Willemse, P M
Burggraaf, J
Hamdy, N A T
Weijl, N I
Vossen, C Y
van Wulften, L
van Steijn-van Tol, A Q M J
Rosendaal, F R
Osanto, S
author_facet Willemse, P M
Burggraaf, J
Hamdy, N A T
Weijl, N I
Vossen, C Y
van Wulften, L
van Steijn-van Tol, A Q M J
Rosendaal, F R
Osanto, S
author_sort Willemse, P M
collection PubMed
description
format Online
Article
Text
id pubmed-3708557
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-37085572013-07-13 Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors Willemse, P M Burggraaf, J Hamdy, N A T Weijl, N I Vossen, C Y van Wulften, L van Steijn-van Tol, A Q M J Rosendaal, F R Osanto, S Br J Cancer Corrigendum Nature Publishing Group 2013-07-09 2013-07-09 /pmc/articles/PMC3708557/ http://dx.doi.org/10.1038/bjc.2013.358 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Corrigendum
Willemse, P M
Burggraaf, J
Hamdy, N A T
Weijl, N I
Vossen, C Y
van Wulften, L
van Steijn-van Tol, A Q M J
Rosendaal, F R
Osanto, S
Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
title Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
title_full Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
title_fullStr Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
title_full_unstemmed Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
title_short Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
title_sort prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708557/
http://dx.doi.org/10.1038/bjc.2013.358
work_keys_str_mv AT willemsepm prevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors
AT burggraafj prevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors
AT hamdynat prevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors
AT weijlni prevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors
AT vossency prevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors
AT vanwulftenl prevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors
AT vansteijnvantolaqmj prevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors
AT rosendaalfr prevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors
AT osantos prevalenceofthemetabolicsyndromeandcardiovasculardiseaseriskinchemotherapytreatedtesticulargermcelltumoursurvivors